Neurotherapeutics

该政策规定:不允许在投稿稿件中使用生成式AI或AI辅助工具创建或修改图像;唯一例外是AI或AI辅助工具的使用属于研究设计或方法的一部分(例如生物医学成像领域),此时必须在方法部分以可复现的方式描述该使用,包括模型或工具的名称和版本。 模型中文摘要

Please read our policy on the use of generative AI and AI-assisted tools in figures, images and artwork, which can be found in Elsevier’s GenAI Policies for Journals. This policy states:We do not permit the use of Generative AI or AI-assisted tools to create or alter images in submitted manuscripts.The only exception is if the use of AI or AI-assisted tools is part of the research design or method…

该政策规定:作者应在投稿前仔细考虑作者名单及顺序,并在首次投稿时提供确定的作者名单;任何作者姓名的增删或重排只能在稿件被接受之前且经期刊编辑批准后进行;申请此类变更时,编辑必须收到通讯作者提供的(a)变更作者名单的原因和(b)所有作者同意该变更的书面确认(电子邮件或信函)。 模型中文摘要

Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, …

该政策规定:所有作者必须披露可能与他人或组织存在的不当影响(偏见)其工作的任何财务和个人关系;潜在竞争利益的例子包括雇佣、咨询、持股、酬金、付费专家证言、专利申请/注册以及资助或其他资金;作者必须在两处披露利益:1. 标题页文件(双匿名)或稿件文件(单匿名)中的利益声明摘要;如无利益可声明,则需声明无利益。 模型中文摘要

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:…

该政策规定:Neurotherapeutics 是一本完全开放获取的期刊,更多信息请访问其开放获取页面。 模型中文摘要

Neurotherapeutics is a fully Open Access Journal. Please visit our Open Access Page for more information.

该政策规定:该期刊采用单匿名评审流程;所有投稿首先由编辑评估是否适合该期刊;被认为合适的论文通常会送至少两名独立专家评审以评估论文的科学质量;编辑对文章接受或拒绝负有最终决定责任,编辑的决定是最终的;编辑不参与涉及自身、家庭成员或同事所写论文,或涉及编辑有利益的产品或服务的论文的决定。 模型中文摘要

This journal operates a single anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…

该政策规定:预印本可以随时随地在任何地方共享,符合Elsevier的共享政策;例如在预印本服务器上共享预印本不会被视为先前发表。 模型中文摘要

Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).